Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 676

1.

Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials.

Moreira ED Jr, Block SL, Ferris D, Giuliano AR, Iversen OE, Joura EA, Kosalaraksa P, Schilling A, Van Damme P, Bornstein J, Bosch FX, Pils S, Cuzick J, Garland SM, Huh W, Kjaer SK, Qi H, Hyatt D, Martin J, Moeller E, Ritter M, Baudin M, Luxembourg A.

Pediatrics. 2016 Jul 15. pii: e20154387. [Epub ahead of print]

PMID:
27422279
2.

Medicinal Plants Used for Treating Reproductive Health Care Problems in Cameroon, Central Africa1.

Tsobou R, Mapongmetsem PM, Van Damme P.

Econ Bot. 2016;70:145-159. Epub 2016 May 17.

3.

Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014.

Sabbe M, Berger N, Blommaert A, Ogunjimi B, Grammens T, Callens M, Van Herck K, Beutels P, Van Damme P, Bilcke J.

Euro Surveill. 2016 Jul 7;21(27). doi: 10.2807/1560-7917.ES.2016.21.27.30273.

PMID:
27418466
4.

Comparison between urine and cervical samples for HPV DNA detection and typing in young women in Colombia.

Combita AL, Gheit T, Gonzalez P, Puerto D, Murillo RH, Montoya L, Vorsters A, Van Keer S, Van Damme P, Tommasino M, Hernandez-Suarez G, Sanchez L, Herrero R, Wiesner C.

Cancer Prev Res (Phila). 2016 Jul 14. pii: canprevres.0038.2016. [Epub ahead of print]

PMID:
27417431
5.

Achieving WHO recommendations for Hepatitis C Virus Elimination in Belgium.

Bourgeois S, Blach S, Blach C, Laleman W, Matheï C, Mulkay JP, Ravazi H, Robaeys G, Stärkel P, Van Damme P, Van Vlierberghe H, Vandijck D, Vandijck C.

Acta Gastroenterol Belg. 2016 Apr-Jun;79(2):222-6.

PMID:
27382942
6.

Genetic ablation of IP3 receptor 2 increases cytokines and decreases survival of SOD1G93A mice.

Staats KA, Humblet-Baron S, Bento-Abreu A, Scheveneels W, Nikolaou A, Deckers K, Lemmens R, Goris A, Van Ginderachter JA, Van Damme P, Hisatsune C, Mikoshiba K, Liston A, Robberecht W, Van Den Bosch L.

Hum Mol Genet. 2016 Jul 4. pii: ddw190. [Epub ahead of print]

7.

A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men.

Van Damme P, Meijer CJ, Kieninger D, Schuyleman A, Thomas S, Luxembourg A, Baudin M.

Vaccine. 2016 Jul 29;34(35):4205-12. doi: 10.1016/j.vaccine.2016.06.056. Epub 2016 Jun 25.

8.

Inside out: the role of nucleocytoplasmic transport in ALS and FTLD.

Boeynaems S, Bogaert E, Van Damme P, Van Den Bosch L.

Acta Neuropathol. 2016 Aug;132(2):159-73. doi: 10.1007/s00401-016-1586-5. Epub 2016 Jun 6. Review.

PMID:
27271576
9.

Prevalence of high-risk human papillomavirus and abnormal pap smears in female sex workers compared to the general population in Antwerp, Belgium.

Vorsters A, Cornelissen T, Leuridan E, Bogers J, Vanden Broeck D, Benoy I, Goossens H, Hens N, Van Damme P.

BMC Public Health. 2016 Jun 7;16:477. doi: 10.1186/s12889-016-3099-5.

10.

Global progress in the control of viral hepatitis and acceptable delay in Hepatitis B immunization.

Kane MA, Roudot-Thoraval F, Guerin N, Papaevangelou V, Van Damme P; Viral Hepatitis Prevention Board.

Hum Vaccin Immunother. 2016 Jun 3:1-4. [Epub ahead of print]

PMID:
27261211
11.

GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial.

Van Damme P, Bouillette-Marussig M, Hens A, De Coster I, Depuydt C, Goubier A, Van Tendeloo V, Cools N, Goossens H, Hercend T, Timmerman B, Bissery MC.

Clin Cancer Res. 2016 Jul 1;22(13):3238-48. doi: 10.1158/1078-0432.CCR-16-0085. Epub 2016 Jun 1.

PMID:
27252412
12.

Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis.

Fogh I, Lin K, Tiloca C, Rooney J, Gellera C, Diekstra FP, Ratti A, Shatunov A, van Es MA, Proitsi P, Jones A, Sproviero W, Chiò A, McLaughlin RL, Sorarù G, Corrado L, Stahl D, Del Bo R, Cereda C, Castellotti B, Glass JD, Newhouse S, Dobson R, Smith BN, Topp S, van Rheenen W, Meininger V, Melki J, Morrison KE, Shaw PJ, Leigh PN, Andersen PM, Comi GP, Ticozzi N, Mazzini L, D'Alfonso S, Traynor BJ, Van Damme P, Robberecht W, Brown RH, Landers JE, Hardiman O, Lewis CM, van den Berg LH, Shaw CE, Veldink JH, Silani V, Al-Chalabi A, Powell J.

JAMA Neurol. 2016 Jul 1;73(7):812-20. doi: 10.1001/jamaneurol.2016.1114.

PMID:
27244217
13.

Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial.

Leroux-Roels G, Marchant A, Levy J, Van Damme P, Schwarz TF, Horsmans Y, Jilg W, Kremsner PG, Haelterman E, Clément F, Gabor JJ, Esen M, Hens A, Carletti I, Fissette L, Tavares Da Silva F, Burny W, Janssens M, Moris P, Didierlaurent AM, Van Der Most R, Garçon N, Van Belle P, Van Mechelen M.

Clin Immunol. 2016 May 25;169:16-27. doi: 10.1016/j.clim.2016.05.007. [Epub ahead of print]

14.

Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: A systematic review using individual patient data.

Geevasinga N, Loy CT, Menon P, de Carvalho M, Swash M, Schrooten M, Van Damme P, Gawel M, Sonoo M, Higashihara M, Noto Y, Kuwabara S, Kiernan MC, Macaskill P, Vucic S.

Clin Neurophysiol. 2016 Jul;127(7):2684-91. doi: 10.1016/j.clinph.2016.04.005. Epub 2016 Apr 16.

PMID:
27212114
15.

Long-Term Follow-up of HPV Infection Using Urine and Cervical Quantitative HPV DNA Testing.

Vorsters A, Van Keer S, Biesmans S, Hens A, De Coster I, Goossens H, Ieven M, Van Damme P.

Int J Mol Sci. 2016 May 17;17(5). pii: E750. doi: 10.3390/ijms17050750.

16.

Pertussis vaccination during pregnancy in Belgium: Follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of age.

Maertens K, Caboré RN, Huygen K, Vermeiren S, Hens N, Van Damme P, Leuridan E.

Vaccine. 2016 Jun 30;34(31):3613-9. doi: 10.1016/j.vaccine.2016.04.066. Epub 2016 Apr 30.

PMID:
27142328
17.

Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid).

Esposito S, Bonanni P, Maggi S, Tan L, Ansaldi F, Lopalco PL, Dagan R, Michel JP, van Damme P, Gaillat J, Prymula R, Vesikari T, Mussini C, Frank U, Osterhaus A, Celentano LP, Rossi M, Guercio V, Gavazzi G.

Hum Vaccin Immunother. 2016 Jul 2;12(7):1777-94. doi: 10.1080/21645515.2016.1150396. Epub 2016 May 2.

PMID:
27135390
18.

Phase I, randomized, observer-blind, placebo-controlled studies to evaluate the safety, reactogenicity and immunogenicity of an investigational non-typeable Haemophilus influenzae (NTHi) protein vaccine in adults.

Leroux-Roels G, Van Damme P, Haazen W, Shakib S, Caubet M, Aris E, Devaster JM, Peeters M.

Vaccine. 2016 Jun 8;34(27):3156-63. doi: 10.1016/j.vaccine.2016.04.051. Epub 2016 Apr 29.

19.

Myasthenia gravis with muscle specific kinase antibodies mimicking amyotrophic lateral sclerosis.

Huijbers MG, Niks EH, Klooster R, de Visser M, Kuks JB, Veldink JH, Klarenbeek P, Van Damme P, de Baets MH, van der Maarel SM, van den Berg LH, Verschuuren JJ.

Neuromuscul Disord. 2016 Jun;26(6):350-3. doi: 10.1016/j.nmd.2016.04.004. Epub 2016 Apr 6.

PMID:
27133662
20.

Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs.

Jiang J, Zhu Q, Gendron TF, Saberi S, McAlonis-Downes M, Seelman A, Stauffer JE, Jafar-Nejad P, Drenner K, Schulte D, Chun S, Sun S, Ling SC, Myers B, Engelhardt J, Katz M, Baughn M, Platoshyn O, Marsala M, Watt A, Heyser CJ, Ard MC, De Muynck L, Daughrity LM, Swing DA, Tessarollo L, Jung CJ, Delpoux A, Utzschneider DT, Hedrick SM, de Jong PJ, Edbauer D, Van Damme P, Petrucelli L, Shaw CE, Bennett CF, Da Cruz S, Ravits J, Rigo F, Cleveland DW, Lagier-Tourenne C.

Neuron. 2016 May 4;90(3):535-50. doi: 10.1016/j.neuron.2016.04.006. Epub 2016 Apr 21.

PMID:
27112497
Items per page

Supplemental Content

Loading ...
Write to the Help Desk